☰ Menu
  • Accessibility
  • Contact us

Policies and procedures

‹ Return to search

Medicines Formulary Policy (PHA25)


The Trust Drug and Therapeutics Group reports to the Executive Board through the Quality Committee with respect to decision making on the introduction of new medicines. The controlled and rational introduction of new medicines is a requirement specified by the Care Quality Commission.
Date created: 21 March 2017
Last modified: 2 August 2017

Leave feedback